Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Juan Marcos Gonzalez"'
Autor:
Carrie Dombeck, Teresa Swezey, Juan Marcos Gonzalez Sepulveda, Bryce B. Reeve, Thomas W. LeBlanc, David Chandler, Amy Corneli
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Advances in multiple myeloma treatment and a proliferation of treatment options have resulted in improved survival rates and periods of symptom-free remission for many multiple myeloma patients. As a result, health-related quality
Externí odkaz:
https://doaj.org/article/7bcad58b71124c429565d7e34b6cea9d
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0287766 (2023)
BackgroundOnline administration of surveys has a number of advantages but can also lead to increased exposure to bad actors (human and non-human bots) who can try to influence the study results or to benefit financially from the survey. We analyze da
Externí odkaz:
https://doaj.org/article/9d5842e7612e44888d763f398dc70fb2
Autor:
J. Felipe Montano-Campos, Juan Marcos Gonzalez, Timothy Rickert, Angelyn O. Fairchild, Bennett Levitan, Shelby D. Reed
Publikováno v:
MDM Policy & Practice, Vol 8 (2023)
Background and Objectives. Risk-tolerance measures from patient-preference studies typically focus on individual adverse events. We recently introduced an approach that extends maximum acceptable risk (MAR) calculations to simultaneous maximum accept
Externí odkaz:
https://doaj.org/article/d3cbc17e2e454708b7dc2e73df02e986
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
PurposeImmunoglobulin (Ig) replacement therapy is an important life-saving treatment modality for patients with primary antibody immune deficiency disorders (PAD). IVIG and SCIg are suitable alternatives to treat patients with PAD but vary in key way
Externí odkaz:
https://doaj.org/article/3bce66c006df4d2a9fc6d56f5437ff5b
Autor:
A. Brett Hauber, Ateesha F. Mohamed, Juan Marcos Gonzalez, Angelyn Otteson Fairchild, Susan C. Zelt, Ole Graff
Publikováno v:
Journal of Dermatological Treatment, Vol 28, Iss 1, Pp 40-46 (2017)
Hand eczema affects approximately 16% of the US population. The long-term prognosis is poor, and 5–7% experience severe chronic hand eczema (sCHE) that interferes with daily activities. Treatments for CHE may be ineffective or associated with adver
Externí odkaz:
https://doaj.org/article/2c25d00107bb4db1adbfb7972589b23e
Autor:
Penvose, Katherine N., Reed, Shelby D., Sepulveda, Juan Marcos Gonzalez, Mastylak, Alicja, Scott, Amelia, Hayes, Taylor, Shank, Juliana, Havrilesky, Laura J.
Publikováno v:
In Gynecologic Oncology February 2024 181:91-98
Publikováno v:
In Journal of Pain and Symptom Management April 2022 63(4):457-467
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ken Okumura, Hiroshi Inoue, Masahiro Yasaka, Juan Marcos Gonzalez, A. Brett Hauber, Bennett Levitan, Zhong Yuan, Jean Baptiste Briere
Publikováno v:
Journal of Health Economics and Outcomes Research
**Background:** Anticoagulants are recommended for stroke prevention in patients with atrial fibrillation (AF), but are associated with an increased risk of bleeding; therefore, physicians face benefit-risk tradeoffs when prescribing anticoagulants t
Externí odkaz:
https://doaj.org/article/1a7dff498d2342aca8b03225fec1ab23
Autor:
F. Reed Johnson, Angelyn Fairchild, Dale Whittington, Amit K. Srivastava, Juan Marcos Gonzalez, Liping Huang
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 16:139-151
Because immunizing large numbers of healthy people could be required to reduce a relatively small number of infections, disease incidence has a large impact on cost effectiveness, even if the infection is associated with very serious health outcomes.